Company Information
USD
1.3
- (-5.1%)
NASDAQ:VYNE, VYNE THERAPEUTICS INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Address
685 Route 202/206 North
Suite 301
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Christine Borowski, PhD
Director
Mr. Patrick G. LePore
Director
Ms. Sharon Surrey-Barbari
Director
Mr. Steven L. Basta
Director
Mr. Anthony D Bruno
Director
Ms. Elisabeth A. Sandoval-Little
Director
Mr. David Domzalski
CEO/Director/President
Mr. Iain A. Stuart, PhD
Chief Scientific Officer
Ms. Mutya Harsch
Chief Legal Officer/General Counsel/Secretary
Mr. Tyler Zeronda
CFO/Chief Accounting Officer/Treasurer
Ownership
Institution Holdings
Eventide Asset Management, LLC
1,394,336 (9.890%)
Cormorant Asset Management, LLC
1,394,336 (9.890%)
Citadel Advisors Llc
1,181,088 (8.377%)
Soleus Capital Management, L.P.
703,868 (4.992%)
Parkman Healthcare Partners LLC
696,470 (4.940%)
AlphaCentric Advisors, LLC
668,151 (4.739%)
AlphaCentric Advisors LLC
668,151 (4.739%)
Palo Alto Investors, LLC
445,434 (3.159%)
Springbok Capital Management, LLC
118,100 (0.838%)
Dsc Advisors LP
115,000 (0.816%)
Individual Holdings
Mr. Steven L. Basta
536,537 (62.813%)
Mr. David Domzalski
495,164 (3.548%)
Ms. Sharon Surrey-Barbari
75,000 (3.220%)
Ms. Mutya Harsch
149,435 (1.071%)
Mr. Iain A. Stuart, PhD
133,898 (0.959%)
Mr. Tyler Zeronda
131,837 (0.945%)
Mr. Patrick G. LePore
36,472 (0.261%)
Funds Holdings
Alger LIfe Sciences Innovation Composite
60,055 (0.426%)
Vanguard Institutional Extnd Mkt Idx Tr
50,078 (0.355%)
BlackRock Extended Equity Market
5,222 (0.037%)
Extended Equity Market Fund M
646 (0.005%)
SSgA U.S. Total Market Index Fund
281 (0.002%)
BNYM Mellon SL Market Completion Fund
196 (0.001%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
